In addition, through screening on a 3D proteome-wide scale and activity evaluation, MV1035 could reduce U87 glioblastoma cell line migration as a new ALKBH5 inhibitor (Malacrida et al., 2020). The gene discussed is ALKBH5; the disease is glioblastoma.